PSI is the one CRO that I can honestly say not only met the target accrual of patients to a challenging clinical trial but even exceeded it. What struck me most is the high level of dedication, expertise and training at all levels and it is that element that allows PSI to be so successful. A study that stays on time also has a much better chance to stay on budget and we clearly benefitted from that discipline. All in all, PSI is always the first consideration when we are discussing new studies.
